Xuanzhu Biopharmaceutical Co., Ltd.
Xuanzhu Biopharmaceutical Co., Ltd.
Explore linked clinical trials.11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Clinical Trail to Evaluate the Efficacy and Safety of Anaprazole Sodium Enteric-coated Tablets Combined With Bismuth-containing Quadruple Therapy in Eradicating Helicobacter Pylori | HELICOBACTER PYLORI INFECTIONS | Not yet recruiting | Phase 3 | 2026-05-26 | NCT07606833 | |
| A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations | Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hepatic Insufficiency, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, kidney failure, liver disorder, urinary system disorder | Not yet recruiting | Phase 4 | 2026-01-16 | NCT07345689 | |
| Drug-drug Interaction Study of Rifampin and Anaprazole Sodium | Drug-drug Interaction Study | Not yet recruiting | Phase 4 | 2026-01-09 | NCT07330531 | |
| A Clinical Trial of Anaprazole for Treating Reflux Esophagitis. | Digestive System Diseases, digestive system disorder, duodenal disorder, esophageal disorder, esophagitis, gastroenteritis, intestinal disorder, peptic esophagitis, peptic ulcer disease, stomach disorder | Recruiting | Phase 3 | 2025-09-29 | NCT07010107 | |
| A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2025-07-17 | NCT05257395 | |
| A Study of XZB-0004 in Patients With Solid Tumors | non-small cell lung carcinoma | Recruiting | Phase 1 | 2024-10-28 | NCT05772455 | |
| A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2024-05-24 | NCT05077449 | |
| A Study of KM501 in Patients With Solid Tumors | Advanced Solid Tumors | Not yet recruiting | Phase 1 | 2023-04-07 | NCT05804864 | |
| A Study of KM602 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Not yet recruiting | Phase 1 | 2023-03-13 | NCT05766527 | |
| A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2022-08-30 | NCT04996121 | |
| A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors. | Advanced Solid Tumor | Not yet recruiting | Phase 1 | 2022-04-11 | NCT05320874 |